Showing results (551-560 of 1,193) with videos related to

Sort By:
Pageof 120
Bone Marrow Transplantation|April 1, 1994
Influenza A virus infections among hospitalized adult bone marrow transplant recipientsE Whimbey, L S Elting, R B Couch, et al.
Chemotherapy|January 1, 1986
In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patientsK V Rolston, M E Alvarez, J F Hoy, et al.
Molecular and Cellular Biology|February 1, 1992
Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemiaK S Chang, S A Stass, D T Chu, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Cancer Genetics and Cytogenetics|January 1, 1988
The myeloperoxidase gene is translocated from chromosome 17 to 15 in a patient with acute promyelocytic leukemiaJ C Liang, K S Chang, W T Schroeder, et al.
Acta Haematologica|January 1, 1987
Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemiaH M Kantarjian, M Talpaz, R Kurzrock, et al.
Hematologic Pathology|January 1, 1987
Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemiaE H Estey, M J Keating, D O Dixon, et al.
Acta Haematologica|January 1, 1987
Comparison of results of salvage therapy in adult acute myelogenous leukemiaM J Keating, E Estey, H M Kantarjian, et al.
Cancer|March 1, 1989
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Pageof 120